Category: Technology Licenses
Created On: 2022-04-28
Record Count: 7
- Wound Care
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 383121
Buyer will non-exclusively license, sublicense, lease, or sublease equipment that is not owned by Seller but is used for the production of Wound Care Assets.
IPSCIO Record ID: 304408
Licensor manufactures the products and owns the CellerateRX registered trademark.
Partial- and full-thickness wounds
First- and second-degree burns
Licensee will utilize the wound and skin care products for external wounds, including the treatment of external, tunneled or undermined wounds. These products are used by surgeons in the medical industry. This would include pressure ulcers (Stages I-IV), venous stasis ulcers, diabetic ulcers, ulcers resulting from arterial insufficiency, surgical wounds, traumatic wounds, first and second-degree burns, superficial wounds, cuts, scrapes, skin tears, skin flaps and skin grafts.
The Licensees business is developing, marketing, and distributing wound and skin care products to physicians, hospitals, clinics and post-acute care settings.
IPSCIO Record ID: 614
Patent means – United States Patent No. 6,136,341.
The patented technologies and processes related to CellerateRxTM, an advanced collagen based wound care product formulation. These new licenses are limited to the human health care market for external wound care, and include any new product developments based on the licensed patent and processes.
IPSCIO Record ID: 237112
The AurixÂ® System is used at point-of-care for the safe and rapid preparation of biodynamic hematogel from a small sample of a patientâ€™s own blood.
IPSCIO Record ID: 26365
IPSCIO Record ID: 287103
The Companys affiliate conducts operations with an exclusive sublicense from the Licensors affiliate to distribute Licensees products into the wound care and surgical markets in the United States, Canada and Mexico.
CellerateRXÂ® Gel is a hydrolyzed collagen wound dressing (approximately 65% type I collagen).
The Companyâ€™s business is developing, marketing, and distributing wound and skin care products to physicians, hospitals, clinics and post-acute care settings.
IPSCIO Record ID: 256319
The patents are Wound Dressing and Treatment Method, Fluidic Connection System and Method, and, Fastening System and Method.